Selective Alpha adrenergic Receptor Agonist Flashcards
Selective alpha 1 antagonists
competivive
reversitbel, ALL 3 subtyps (Alpha1a, alpha 1b, alpha 1d)
NO ALPHA 2 ANTAGONIST
Primary use of alpha 1 adrenergic
What is an alternative to Phenoxybenzamine?
Used for BPH
Prazosin as an ALTERNATIVE to phenoxybenxamine
Seleactive Alpha adrenergic receptor CV
Greater vasodilation at veins and arteries
Selective alpha 1 adrenergic found where?
found in bladder
Adverse effects
Orthostatic hypotension, fluid retention, vertigo, syncope and nasal congestion
The administration of usual doses of
an alpha 1 agonists such as phenylephrine may not produce the desired effect in patients , MAY HAVE TO GIVE SLIGHLY MORE MEDS
Selective ALPHA 1 A receptor antagonists
Tamsulosin, Silodosin
Both selective, competitive post synaptic alpha 1 a antagonists
Alpha 1 a : BLADDER and PROSTATIC TISSUE
Mechanism of action
Selectively inhbiti alpha 1a recepotrs found in smooth muscle in the bladder base, bladder necks, prostatic capsule
Beta adrenergic Receptor Antagonists
Bind selectively, reversibly and competitively to beta adrenergic recepotrs and INHIBIT catecholamins, and other sympathomimetics –> Decreased adenylate cyclase which decreases the concertation of cAMP
Beta adrenergic antagonist main pharm effect
Mechanism of INVERSE AGONIST
More drugs to compete
ccompetitive reversible.
Classification of Beta adrenergic
Receptor antagonized intrinsic sympathomimetic difference in lipid solubility Membrane stabilizing effects Differences in pharmacokinetic profile.
Beta adrenergic receptor antagonists
Non selective beta or cardio selective
Non selective beta adrenergic agonists
Beta 1 and beta 2
INhibit chrono, ino, and vasodilator responses
Propanolol, nadolol,, sotalol, timolol, carvedilol, labetalol, carteolol, pinolol
Cardio selecte beta 1 ANTAGONISTS
Less likely to proDUCE BRONCHOSPASM
vASOCONSTRICITION
AND ALTER METABOLIC EFFECTS
It is imnt to recognize that cardioselectily is dose dependent and beta 1 selectivity is lost whe
higher larger doses of these agents are administered and they can inhbiti beta 2 recepots
It is important to recognize that cardioselectily is dose dependent and beta 1 selectivity is lost whe
higher larger doses of these agents are administered and they can inhbiti beta 2 recepots
Intrisic Sympathomimetic Activity
Can actually have slight AGONIST effect even though it is an antagonists
ISA means
But when endogenous NE is high
ISA means that the beta adrenergic antagonist demonstrates a PARTIAL AGONISTS effect at the beta receptor site and will partially activate the beta receptor If the concentration of endogenous NE is LOW, as in resting state.
But when endogenous NE is high, these agents will still be occupying beta receptors and the overall effect will be antagonism of NE effects
ISA agents cause less direct myocardial depression and result in
less bradycardia than agents that do not have ISA
Bottom line for the anesthesia providers: ISA
DONT USE THEM IN PATIENT UNLESS YOU HAVE TO
Beta adrenergic antagonists that have ISA are to be used in
Extreme caution with HR diseases.
Lipid solubility
Beta blocker high , mod, or high lipophilicity
High cross BB, decrease SNS outflow by antagonizing beta receptors.
Post op propranolol
Lethargy
Vivid dreams
The highest lipid soluble beta blocker is
PROPANOLOL
MSA (not releveant at normal doses ONLY IN
TOXICITY
Membrane Stabilizing activity
Can inhibit fast Na channels in the heart
Quinidine 1a antiarrythymic agents
MSA meds
Propanolol Acebutolol Carvedilol Metoproplol Pindolol Labetalol Nebidolol
Elmination of esmolol
Esterases in Cytosol of RBCs
Half life 9 minutes.
Know nonselective or CARDIOSELECTIve agents
BOLD : drugs, know ISA< MSA
Beta blocker uses : TAPIE
Essential HTN ACS Tachyarrythmia Intra op HTN Preventative to prevent negative outcomes
Anesthesia purpose use of Beta Blockers
Prevention of excessive SNS activity with
Direct laryngeal and tracheal intubation
Hypertrophic obstructive cardiomyopathies
Hyperthyroidism
Cyanotic
baroreceptor reflex
anxiety and panic attacks
*****PERIOPERATIVE USE OF Beta BLOCKERS
Patients are Risk for Myocardia ischemia (or previous MI) Known CAD Diabetic LVH Positive PRE-OP stress test At risk for MI, from a certain surgeries
The general goal is a resting HR between 65-80 per minute
Avoid using beta adrenergic receptor antagonist that POSSES INTRINCIS sympathomimetic activity for this indication.
Beta Blockers MOA on NODAL ‘
_______automaticity
_________Sinus rate
__________AV nodal conduction velocity
________ Refractory period of the AV node
_________ PR interval
________ chronotrope and dromotropic effects
_________SLOPE OF PHASE 4 SPONTANEOUS DEPOLARIZATION
Decrease automaticity
Decrease Sinus rate
Slows AV nodal conduction velocity
Increased Refractory period of the AV node
Lengthens PR interval
Negative chronotrope and dromotropic effects
DECREASE SLOPE OF PHASE 4 SPONTANEOUS DEPOLARIZATION
Beta blockers MOA on Myocytes
___________ phase 2 of the fast action potential
__________ force of contraction in cardiac muscle cells
________ inotrope effects
These agent reset the baroreceptors reflex ___________
Decreases phase 2 of the fast action potential
Decrease force of contraction in cardiac muscle cells
Negative inotrope effects
These agent reset the baroreceptors reflex DOWNWARD
Beta blockers on PVR and Afterload?
Decrease PVR which will decrease afterload
Cardiac effects of Beta blockers
HR< FOC< CO, PVR, Diastolic filling, myocardial oxygen demand.
Decreased HR Decreased FOC Decreased CO Decreased PVR Increase DIASTOLIC FILLING time Decrease myocardial oxygen demand
No beta blockers for patients with
AV blocks
Non selective beta adrenergic agonists inhibits
VASODILATION of the beta agonists such as ISOPROTERENOL
The cardio stimulating effects of
CALCIUM
GLUCAGON
DIGOXIN
are not effected by beta adrenergic antagonists.
Non selective beta adrenergic antagnostis enehcnaeg
the pressor response to epinephrine since non selective beta adrenergic antagnosits prevent the beta 2 vasodilating effects of epinephrine and leave UNOPPOSED alpha 1 mediated vasocontasticn which can lead to exaggerated HTN
Beta adredergic receptor antagonisms
should only be used after adequate alpha block
PORTAL BLOOD FLOW EFFECTS
Non selective antagonists, reduce by producing splanchnic vasoconstriction thereby reducing portal blood flow .
Portal HTN
Reduces the flow, decrease the pressure
Portal HTN beta blocks user
propranolol
Nadolol
Carvedilol
Non-cardiac effects of beta adrenergic
Beta 2 agonism can lead to bronchoconstriction and increased airway resistance
uSE BETA BLOCKERS WITH bronchospactic effects
Metabolims of
Modify the metabolism of carbohydrate and lipids
Decreased with Glycogenolysis and pancreatic glucagon stimulation can occur, primarily via beta 2 blockadge.
Beta blockers and blood sugar
Type I diabetic patients : mask hypoglycemia
FOr anesthesia, patients with diabetes
ALWAYS give Beta 1 selective antagonists.
ALl beta blockers can interfere
with the counterregulartory effects of catecholamins that are secreted during hypogleycemina by blunting the pereception of tachycardia, tremor and nervousness.
Tachycardia is
an important warning sign fof HYPOGLYCMEIA is BLUNTED AND MASKED BY beta adrenergic antagnoists.
Beta blockers may mask
HYPOGLYCEMIA.